Abstract
The goal of this study was to evaluate the ability of a commercially-available feed supplement (OmniGen-AF) to reduce development of mastitis in a mouse mastitis model. The rationale for completing this study was two-fold. First, dairy producers have reported that OmniGen-AF reduced somatic cell counts and reduced mastitis after the introduction of the product into herds. Second, recent studies have shown that the product increased markers of both innate and adaptive immunity. Our hypothesis, therefore, was that feeding the product would reduce the development and severity of mastitis in a mouse model. To assess this hypothesis, five experiments were completed with three bovine mastitis isolates. The isolates included Streptococcus uberis (S. uberis), Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Association of Bovine Practitioners Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
